1. Wild S, Roglic G et al. Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–53.
2. Дедов И.И., Ремизов О.В., Петеркова В.А. Сахарный диабет второго типа у детей и подростков. Сахарный диабет 2001; 4: 26–31.
3. Partanen J, Niskanen L, Lehtinen J et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 89–94.
4. Young MJ, Boulton AJ, MacLeod AF et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36:150–4.
5. Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med 2008; 9 (6): 660–74.
6. Данилов А.Б., Давыдов О.С. Нейропатическая боль. М.: Боргес, 2007.
7. Boulton AJM, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2008; 28: 5956–62.
8. Левин О.С. Полинейропатии. М.: Медицинское информационное агентство, 2005.
9. Writing Team for the DCCT/EDIC Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287: 2563–9.
10. UKPDS 33. Lancet 1998; 352: 837–53.
11. Adler AI, Boyko EJ, Ahroni JH et al. Risk factors for diabetic peripheral sensory neuropathy: results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997; 20: 1162–7.
12. Martin CL, Albers J, Herman WH, Cleary P. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 2006; 29: 340–4.
13. Строков И.А., Баринов А.Н. Клиника, патогенез и лечение болевого синдрома при диабетической полинейропатии. Неврол. журн. 2001; 6: 47–55.
14. Max MB, Lynch SA, Muir J et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250–6.
15. Данилов А.Б., Раймкулова О.К. Лечение болевых синдромов антидепрессантом венлафаксином. Журн. неврологии и психиатрии. 2009; 1: 76–9.
16. Sindrup SH, Bach FW, Madsen C et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003; 60: 1284–9.
17. Finnerup NB, Otto M, McQuay HJ et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289–305.
18. Vinik A, Pittenger G, Anderson A et al. Topiramate improves C-fiber neuropathy and features of the dysmetabolic syndrome in type 2 diabetes. Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association; June 13-17, New Orleans, Louisiana 2003, Abstract A130.
19. Papp J, Simpson DM. Safety profile of treatment in diabetic peripheral neuropathic pain. Pain Med 2007; 8 (Suppl. 2): S43–49.
20. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83: 163–8.
21. Arezzo JC, Rosenstock J, La Moreaux L, Pauer L. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol 2008; 8: 33.
22. Backonja M, Beydoun A, Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280: 1831–6.
23. Freeman R, Rosenstock J, Emir B, Durso-Deeruz E. Pooled analysis of 7 randomized, controlled trials of pregabalin for the treatment of painful diabetic peripheral neuropathy (DPN): efficacy, safety, tolerability. Diabetologia 2007; 50 (1): 62–3.
24. Bril V, England J, Franklin GM et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76: 1–8.
25. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy. Arandomized controlled trial. Neurology 2003; 60: 927–34.
26. Harati Y, Gooch C, Swenson M et al. Double-blind randomized trial of tramadol for the treatment of diabetic neuropathy. Neurology 1998; 50: 1842–6.

В.Н.Шишкова

ГБУЗ Центр патологии речи и нейрореабилитации, Москва